Intervention for Non-Small Cell Lung Cancer
Cross Cancer Institute, Edmonton, Canada
InterventionN/AWaitlist AvailableLed by Vera Mazurak, Ph.D.Research Sponsored by University of AlbertaEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with a newly confirmed diagnosis of non-small cell lung cancer scheduled for first line chemotherapy
Patients with a computed tomography (CT) image, which includes scans of the 3rd lumbar region, taken within 45 days before initiation of chemotherapy
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up12 weeks
Awards & highlights
No Placebo-Only Group
Study Summary
This trial looks at whether adding certain foods to your diet during chemotherapy helps adults with non-small cell lung cancer.
Eligible Conditions
- Non-Small Cell Lung Cancer
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes in muscle mass
Secondary outcome measures
Change in inflammatory status
Change in muscle strength
Change in nutritional status
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Subjects will add certain foods to what they normally eat.
Group II: Non-experimental interventionActive Control1 Intervention
Subjects will continue eating normally.
Find a site
Who is running the clinical trial?
University of AlbertaLead Sponsor
864 Previous Clinical Trials
390,744 Total Patients Enrolled
Vera Mazurak, Ph.D.Principal Investigator
University of Alberta1 Previous Clinical Trials
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this study have age restrictions, and if so, who can participate?
"Individuals between the age of 19 and 100 are eligible to participate in this clinical trial."
Answered by AI
Is it possible to still enroll in this clinical experiment?
"The study posted on June 27th of 2017, as evidenced by clinicaltrials.gov, is currently not seeking applicants. Nonetheless, there are over a thousand other trials actively recruiting patients at this moment in time."
Answered by AI
What criteria must be met in order to qualify for participation in this investigation?
"Candidates for this research project must have received antineoplastic agents and be between 19-100 years of age. The total number of allowed participants is approximately 37 individuals."
Answered by AI